TheodosiaAKalfaMD
Pediatric Hematology & Oncology • Cincinnati, OHPediatric Anemia and Red Blood Cell Hematology
Professor of Pediatrics
Dr. Kalfa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
# ML7015
Cincinnati, OH 45229Phone+1 513-636-4266Fax+1 513-636-3549
Summary
- Dr. Theodosia Kalfa is a pediatric hematologist/oncologist in Cincinnati, OH. She received her medical degree from Aristotle University of Thessaloniki School of Medicine and has been in practice 27 years. She also speaks multiple languages, including Greek. She is experienced in thalassemias, bone marrow failure syndromes, hemolytic anemia, pediatric hematology and oncology, and sickle cell disease. She has more than 80 publications and over 500 citings.
Education & Training
Duke University HospitalFellowship, Pediatric Hematology/Oncology, 2000 - 2003
University of North Carolina HospitalsResidency, Pediatrics, 1996 - 1999
Aristotle University of Thessaloniki School of MedicineClass of 1990
Certifications & Licensure
OH State Medical License 2003 - 2026
IN State Medical License 2021 - 2025
KY State Medical License 2021 - 2025
NC State Medical License 1996 - 2009- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- The Congenital Dyserythropoietic Anemia Registry (CDAR) Start of enrollment: 2016 Aug 29
- A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients Start of enrollment: 2018 Dec 11
- Imatinib for Pain in Sickle Cell Anemia Start of enrollment: 2020 Feb 26
Publications & Presentations
PubMed
- 300 citationsHydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia - TCD with Transfusions Changi...Russell E. Ware, Barry R. Davis, William H. Schultz, R. Clark Brown, Banu Aygun
Lancet. 2016-02-13 - 6 citationsAutomated Oxygen Gradient Ektacytometry: A Novel Biomarker in Sickle Cell Anemia.Alina Sadaf, Katie G. Seu, Elizabeth Thaman, Rose Fessler, Diamantis G. Konstantinidis
Frontiers in Physiology. 2021-03-25 - 183 citationsBase editing of haematopoietic stem cells rescues sickle cell disease in mice.Gregory A. Newby, Jonathan Yen, Kaitly J. Woodard, Thiyagaraj Mayuranathan, Cicera R. Lazzarotto
Nature. 2021-06-02
Journal Articles
- nicheKalfa, Blood
Abstracts/Posters
- Congenital Dyserythropoietic Anemia Type I Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR)Theodosia A. Kalfa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- VPS4A mutations Cause a Syndrome with Dyserythropoiesis, Hemolytic Anemia, and Neurodevelopmental DelayTheodosia A. Kalfa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
FORMA Therapeutics Announces Clinical Data for Sickle Cell Disease Candidate FT-4202, Demonstrating Multi-Modal Activity of PKR Activation Increases Oxygen Affinity and Decreases Sickle Hemoglobin Polymerization, at 61st Annual ASH MeetingDecember 9th, 2019
Grant Support
- The Role of Erythroblastic Islands in Anemia of InflammationNIH-NHLBI2020–2024
- Rho GTPases in Terminal Erythroid MaturationNIH-NHLBI2012–2016
- RAC1 And RAC2 Guanosine Triphosphatases In Erythroid Function And DifferentiationNational Heart, Lung, And Blood Institute2010–2012
- RAC1 And RAC2 Guanosine Triphosphatases In Erythroid Function And DifferentiationNational Heart, Lung, And Blood Institute2008–2009
Professional Memberships
- Member
- Fellow
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
